A case of unilateral adrenal hyperplasia being difficult to distinguish from aldosterone-producing adenoma

Experimental and Clinical Endocrinology and Diabetes

Volumn 117, Issue 3, 2009, Pages 124-128

  Shigematsu, K ^a   Yamaguchi, N ^a   Nakagaki, T ^a   Sakai, H ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Aldosterone producing adenoma; In situ hybridization; Primary aldosteronism; Spironolactone body; Steroidogenic enzyme; Unilateral adrenal hyperplasia

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; CYTOCHROME P450 17; MESSENGER RNA; STEROID 21 MONOOXYGENASE;

ADRENAL CORTEX ADENOMA; ADRENAL HYPERPLASIA; ADULT; ALDOSTERONE RELEASE; ARTICLE; CASE REPORT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; IN SITU HYBRIDIZATION; NUCLEOTIDE SEQUENCE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; ZONA GLOMERULOSA;

ADENOMA; ADRENAL GLAND NEOPLASMS; ADULT; ALDOSTERONE; ALDOSTERONE SYNTHASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPERPLASIA; RNA, MESSENGER;

EID: 62749194545     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-2008-1078737     Document Type: Article

References (21)

1. Aiba M, Suzuki H, Kageyama K, Murai M, Tazaki H, Abe O, Saruta T. Spironolactone bodies in aldosteronomas and in the attached adrenals. Enzyme histochemical study of 19 cases of primary aldosteronism and a case of aldosteronism due to bilateral diffuse hyperplasia of the zona glomerulosa. Am J Pathol 1981; 103: 404-410
2. Cheng SC, Suzuki K, Sadee W, Harding BW. Effects of spironolactone, canrenone and canrenoate-K on cytochrome P450, and 11beta- and 18-hydroxylation in bovine and human adrenal cortical mitochondria. Endocrinology 1976; 99: 1097-1106
3. Davis DA, Medline NM. Spironolactone (aldactone) bodies: concentric lamellar formations in the adrenal cortices of patients treated with spironolactone. Am J Cin Pathol 1970; 54: 22-32
4. Diner EK, Franks ME, Behari A, Linehan WM, Walther MM. Partial adrenalectomy: the National Cancer Institute experience. Urology 2005; 66: 19-23
5. Fujii H, Kamide K, Miyake O, Abe T, Nagai M, Nakahama H, Horio T, Takiuchi S, Okuyama A, Yutani C, Kawano Y. Primary aldosteronism combined with preclinical Cushing's syndrome in an elderly patient. Circ J 2005; 69: 1425-1427
6. Hsu S-M, Raine L, Martin HF. Spironolactone bodies. An immunoperoxidase study with biochemical correlation. Am J Clin Pathol 1981; 75: 92-95
7. Ishidoya S, Ito A, Sakai K, Satoh M, Chiba Y, Sato F, Arai Y. Laparoscopic partial versus total adrenalectomy for aldosterone producing adenoma. J Urol 2005; 174: 40-48
8. Jenis EH, Hertzog RW. Effects of spironolactone on the zona glomeruosa of the adrenal gland: light and electron microscopy. Arch Pathol 1969; 88: 530-540
9. Jeschke K, Janetschek G, Pesche R, Schellander L, Bartsch G, Henning K. Laparoscopic partial adrenalectomy in patients with aldosterone-producing adenomas: indications, technique, and results. Urology 2003; 61: 69-72
10. Kagawa CM, Cella JA, Arman CG Van. Action of new steroids in blocking effects of aldosterone and deoxycorticosterone on salt. Science 1957; 126: 1015-1016
11. Kanno Y, Suzuki H, Okada H, Takenaka T, Saruta T. Calcium channel blockers versus ACE inhibitors asantihypertensives in polycystic kidney disease. Q J Med 1996; 89: 65-70
12. Liang F, Kapoun AM, Lam A, Damm DL, Quan D, O'Connell M, Protter AA. B-type natriuretic peptide inhibited angiotensin II-stimulated cholesterol biosynthesis, cholesterol transfer, and steroidogenesis in primary human adrenocortical cells. Endocrinology 2007; 148: 3722-3729
13. Magill SB, RaffH, Shaker JL, Brickner RC, Knechtges TE, Kehoe ME, Findling JW. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab 2001; 86: 1066-1071
14. Nakada T, Kubota Y, Sasagawa I, Yagisawa T, Watanabe M, Ishigooka M. Therapeutic outcome of primary aldosteronism: adrenalectomy versus enucleation of aldosterone-producing adenoma. J Urol 1995; 153: 1775-1780
15. Nomura K, Kusakabe K, Maki M, Ito Y, Aiba M, Demura H. Iodomethylnorcholesterol uptake in an aldosteronoma shown by dexamethasonesuppression seintigraphy: relationship to adenoma size and functional activity. J Clin Endocrinol Metab 1990; 71: 825-830
16. Odagiri E, Naruse M, Terasaki K, Yamaguchi N, Jibiki K, Takagi S, Tanabe M, Takano K. The diagnostic standard of preclinical Cushing's syndrome: evaluation of the dexamethasone suppression test using various cortisol kits. Endocr J 2004; 51: 295-302
17. Shigematsu K, Kawai K, Irie J, Sakai H, Nakashima O, Iguchi A, Shimamatsu J, Shimamatsu K, Kusaba Y, Takahara O. Analysis of unilateral adrenal hyperplasia with primary aldosteronism from the aspect of messenger ribonucleic acid expression for steroidogenic enzymes: a comparative study with adrenal cortices adhering to aldosterone-producing adenoma. Endocrinology 2006; 147: 999-1006
18. Spark RF, Dale SL, Kahn PC, Melby JC. Activation of aldosterone secretion in primary aldosteronism. J Clin Invest 1969; 48: 96-104
19. Wheeler MH, Harris DA. Diagnosis and management of primary aldosteronism. World J Surg 2003; 27: 627-631
20. Young Jr WF, Stanson AW, Grant CS, Thompson GB, Heerden JA van. Primary adosteronism: adrenal venous sampling. Surgery 1996; 120 : 913-920
21. Young Jr WF. Minireview: Primary aldosteronism-changing concepts in diagnosis and treatment. Endocrinology 2003; 144: 2208-2213